| Style | Citing Format |
|---|---|
| MLA | Ghafelehbashi R, et al.. "Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy." Clinical and Translational Oncology, vol. 25, no. 1, 2023, pp. 78-90. |
| APA | Ghafelehbashi R, Farshbafnadi M, Aghdam NS, Amiri S, Salehi M, Razi S (2023). Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy. Clinical and Translational Oncology, 25(1), 78-90. |
| Chicago | Ghafelehbashi R, Farshbafnadi M, Aghdam NS, Amiri S, Salehi M, Razi S. "Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy." Clinical and Translational Oncology 25, no. 1 (2023): 78-90. |
| Harvard | Ghafelehbashi R et al. (2023) 'Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy', Clinical and Translational Oncology, 25(1), pp. 78-90. |
| Vancouver | Ghafelehbashi R, Farshbafnadi M, Aghdam NS, Amiri S, Salehi M, Razi S. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy. Clinical and Translational Oncology. 2023;25(1):78-90. |
| BibTex | @article{ author = {Ghafelehbashi R and Farshbafnadi M and Aghdam NS and Amiri S and Salehi M and Razi S}, title = {Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy}, journal = {Clinical and Translational Oncology}, volume = {25}, number = {1}, pages = {78-90}, year = {2023} } |
| RIS | TY - JOUR AU - Ghafelehbashi R AU - Farshbafnadi M AU - Aghdam NS AU - Amiri S AU - Salehi M AU - Razi S TI - Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy JO - Clinical and Translational Oncology VL - 25 IS - 1 SP - 78 EP - 90 PY - 2023 ER - |